Skip to main content
. 2022 Oct 11;11(20):6004. doi: 10.3390/jcm11206004

Figure 2.

Figure 2

Pharmacological treatment of the study population at index. ACE: Angiotensin-converting enzyme; ARB: Angiotensin II receptor blockers; GLP1-RA: Glucagon-like peptide-1 receptor agonists; iDPP4: Dipeptidil peptidasa-4 inhibitors; iSGLT2: Sodium-glucose cotransporter-2; NOAC: Non-vitamin K antagonist oral anticoagulants; VKA: Vitamin K antagonists.